Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04886817 · ClinicalTrials.gov registry record · NA
Intervention to Reduce Sugar-Sweetened Beverage (SSB) Consumption in Children and Families
A NA study of Obesity, Childhood, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT04886817: Completed NA study of Obesity, Childhood, sponsored by Wake Forest University Health Sciences.
NCT04886817 is a NA study of Obesity, Childhood that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 120 participants, below the 341-participant average among 53 other Obesity, Childhood trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04886817, a NA study of Obesity, Childhood, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Pilot randomized trial of a technology-based intervention to reduce sugary drink consumption and promote water intake in families with young children.
Primary Outcome
change in a child's combined consumption of Sugar-Sweetened Beverages (SSB)+Fruit Juice (FJ), measured as total servings per day, at 3 months after starting intervention, measured with Beverage Intake Questionnaire (BevQ15) instrument
Conditions Studied
Interventions
- BEHAVIORAL Pilot Intervention to reduce SSB consumption in children and families
Study Locations (1)
North Carolina
- Wake Forest School of Medicine - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2021-06-17 |
| Est. Completion | 2021-11-18 |
| Phase | NA |
What the finished NCT04886817 record still lists
NCT04886817 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 341-participant average among 53 other Obesity, Childhood trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Obesity, Childhood appearing as the primary indexed condition, and to 1 intervention - of which Pilot Intervention to reduce SSB consumption in children and families is the first listed.
NCT04886817 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04886817 about?
NCT04886817 is a clinical study titled "Intervention to Reduce Sugar-Sweetened Beverage (SSB) Consumption in Children and Families". Pilot randomized trial of a technology-based intervention to reduce sugary drink consumption and promote water intake in families with young children.
What is the current status of trial NCT04886817?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2021-06-17. Estimated completion is 2021-11-18.
What conditions does trial NCT04886817 study?
This clinical trial studies the following conditions: Obesity, Childhood.
What interventions are being tested in trial NCT04886817?
The interventions under investigation include: Pilot Intervention to reduce SSB consumption in children and families (BEHAVIORAL).
Who is sponsoring clinical trial NCT04886817?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04886817 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity, Childhood
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04886817's enrollment target sits among peer trials
120 31st of 53 higher than 21 of 53 other Obesity, Childhood trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity, Childhood trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Increasing Food Literacy in Preschoolers to Reduce Obesity Risk
RECRUITING · NA
-
A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children
RECRUITING · NA
-
Intervention INC: An Interactive Family-centered mHealth Tool to Reduce Obesity Risk in Urban Minority Preadolescents
RECRUITING · NA
-
Food Genetics Behavior Study
RECRUITING · NA
-
Whole Foods for Teens: A Pilot Dietary Intervention to Reduce Body Adiposity in Adolescents With Obesity
RECRUITING · NA
-
Family, Responsibility, Education, Support, and Health for Food Responsiveness
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI